ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $149,785 | -14.9% | 13,679 | +2.8% | 0.00% | 0.0% |
| Q2 2023 | $176,092 | +0.2% | 13,300 | +3.0% | 0.00% | 0.0% |
| Q1 2023 | $175,705 | -30.0% | 12,910 | +0.4% | 0.00% | -50.0% |
| Q4 2022 | $251,156 | +1.7% | 12,860 | -0.8% | 0.00% | 0.0% |
| Q3 2022 | $247,000 | -4.3% | 12,963 | +3.6% | 0.00% | 0.0% |
| Q2 2022 | $258,000 | -30.6% | 12,507 | +8.2% | 0.00% | 0.0% |
| Q1 2022 | $372,000 | -25.6% | 11,563 | +7.7% | 0.00% | -33.3% |
| Q4 2021 | $500,000 | +67.8% | 10,733 | -2.9% | 0.00% | +50.0% |
| Q3 2021 | $298,000 | +2.8% | 11,054 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $290,000 | -26.2% | 11,317 | -1.6% | 0.00% | 0.0% |
| Q1 2021 | $393,000 | +78.6% | 11,502 | +76.6% | 0.00% | 0.0% |
| Q4 2020 | $220,000 | +39.2% | 6,512 | +1.9% | 0.00% | 0.0% |
| Q3 2020 | $158,000 | – | 6,391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |